Results 281 to 290 of about 95,391 (321)
Stents and Drug-Eluting Stents [PDF]
Otolaryngologic Clinics of North America, 2009 Synechiae and ostial stenosis are common and troublesome complications following endoscopic sinus surgery. Many investigators have advocated the use of stents to minimize the risk of postoperative stenosis while others have found their use to be of no benefit. This article reviews the advantages and disadvantages of various stents used in sinus surgery,
Karen A. Bednarski, Frederick A. Kuhn
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Medicine, 2004
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
, 2012 Imad Sheiban has been Associated Professor of Cardiology at the University of Turin, Italy since 2003. Since 1989, he has performed approximately 10,000 procedures of interventional cardiology. He is actively involved in different research programs participating to several international multicenter trials.
Imad Sheiban, Fabrizio D'Ascenzo
openaire +2 more sources
Drug-eluting stents: a reappraisal [PDF]
Heart, 2010 The introduction of drug-eluting stents (DES) in 2002 revolutionised the field of percutaneous coronary intervention (PCI), by significantly reducing rates of restenosis when compared to bare-metal stents (BMS).1 Following this there was a rapid and unprecedented uptake in their use, such that within a matter of years they were used in approximately 80–
Scot Garg, Patrick W. Serruys
openaire +2 more sources
Catheterization and cardiovascular interventions, 2020
There is conflicting evidence about the effects of drug‐coated balloons (DCB) compared with drug‐eluting stents (DES) in patients with native small vessel coronary artery disease (CAD).
J. Sanz Sánchez +7 more
semanticscholar +1 more source
There is conflicting evidence about the effects of drug‐coated balloons (DCB) compared with drug‐eluting stents (DES) in patients with native small vessel coronary artery disease (CAD).
J. Sanz Sánchez +7 more
semanticscholar +1 more source
An Update on Drug-Eluting Stents
Current Treatment Options in Cardiovascular Medicine, 2012Coronary artery disease remains one of the major causes of morbidity and mortality worldwide. Percutaneous coronary intervention has been shown to be an effective treatment for angina pectoris, although it does not provide any prognostic benefit in stable patients.
Scot Garg, Patrick W. Serruys
openaire +4 more sources
In Vitro Drug Release Testing of Special Dosage Forms, 2019
Anne Seidlitz
semanticscholar +3 more sources
Anne Seidlitz
semanticscholar +3 more sources
Nature Clinical Practice Cardiovascular Medicine, 2008
Drug-eluting stents (DESs) effectively reduce angiographic restenosis and the clinical need for repeat revascularization procedures as compared with bare-metal stents. Widely publicized concerns arose recently about the incidence of late and very late stent thrombosis with the use of first-generation DESs.
Peter Jüni, Stephan Windecker
openaire +3 more sources
Drug-eluting stents (DESs) effectively reduce angiographic restenosis and the clinical need for repeat revascularization procedures as compared with bare-metal stents. Widely publicized concerns arose recently about the incidence of late and very late stent thrombosis with the use of first-generation DESs.
Peter Jüni, Stephan Windecker
openaire +3 more sources
In-stent Restenosis of drug-eluting Stents
Future Cardiology, 2013Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Ron Waksman +2 more
openaire +2 more sources
Drug-eluting stents: a critique [PDF]
Heart, 2008 Despite advances in the design of balloons and stents, restenosis remains a major drawback of coronary angioplasty. Multiple randomised trials have demonstrated that drug-eluting stents (DES) can significantly reduce rates of restenosis by 60-75% across both lesion and patient subsets.
William Wijns, Narbeh Melikian
openaire +2 more sources